Status:
RECRUITING
Light Treatment of Vaginal Infections in Reproductive Age Women
Lead Sponsor:
UVISA Health ApS
Collaborating Sponsors:
Odense University Hospital
Conditions:
Bacterial Vaginosis
Vulvovaginal Candidiases
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Antimicrobials have helped in managing vaginal dysbiotic conditions such as bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC). However, their increasing inefficiency and rise in antimicrobia...
Detailed Description
Bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC) are two of the most common vaginal infections, affecting millions of women worldwide. These infections can cause significant discomfort, red...
Eligibility Criteria
Inclusion
- Age 18-45 years of age
- Normal gynecological status
- Diagnosed for BV or VVC
- Not pregnant
- No signs of other genital tract infections
Exclusion
- Current signs of other genital tract infection including STD
- Concomitant medication for treatment of vaginal infections or use of any intravaginal medication during the clinical investigation
- Pregnancy
- Current genital malignancies, chemotherapy for any reason within the last 6 months, previous radiotherapy in the genitourinary system. Cervical dysplasia diagnosis or treatment within the last 3 months (where applicable)
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06985433
Start Date
June 1 2025
End Date
October 1 2025
Last Update
June 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Odense University Hospital
Odense C, Denmark, 5000